| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 05/21/2008 | EP1482924B1 Cathepsin cysteine protease inhibitors |
| 05/21/2008 | EP1362027B1 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical |
| 05/21/2008 | EP0885200B1 Substituted aryl sulphonyl(thio)ureas used as herbicides |
| 05/21/2008 | CN101184758A Novel compounds |
| 05/21/2008 | CN101184734A Compositions and methods of treating cell proliferation disorders |
| 05/21/2008 | CN101182311A New method for removing benzyl from quinazoline molecules containing halogens |
| 05/21/2008 | CN101182310A Method for preparing biphenyl substituted pyrimidine compounds |
| 05/21/2008 | CN101182309A Targeted leading compounds having latent anticancer actives |
| 05/20/2008 | USRE40332 Fungicidal trifluoromethylalkylamino-triazolopyrimidines |
| 05/20/2008 | US7375134 N1-(1-cyanocyclopropyl)-4-fluoro-N2-{(1S)-2,2,2-trifluoro-1-[4'-(methylsulfonyl)-1,1'-biphenyl-4-yl]ethyl}-L-leucinamide; osteoporosis and other bone loss disorders |
| 05/20/2008 | US7375125 Dietetics, cognition activators, cardiovascular disorders, analgesics, immunomoderators |
| 05/20/2008 | US7375108 2-substituted pyrimidines |
| 05/20/2008 | US7375102 inflammatory diseases, immune disorders, multiple sclerosis, rheumatoid arthritis, psoriasis; CXCR3 chemokine receptor modulators; 2-(4-fluoro-3-trifluoromethyl-phenyl)-N-(2-methanesulfonyl-ethyl)-N-(1-{4-oxo-3-[4-(2,2,2-trifluoro-ethoxy)-phenyl]-3,4-dihydro-pyrido[2,3-d]pyrimidin-2-yl}-ethyl)-acetamide |
| 05/20/2008 | CA2395717C Fused imidazolium derivatives |
| 05/20/2008 | CA2350801C Hiv replication inhibiting pyrimidines |
| 05/20/2008 | CA2214685C Benzamidine derivatives their preparation and their use as anti-coagulants |
| 05/15/2008 | WO2008057873A2 Inhibitors of hepatitis c virus |
| 05/15/2008 | WO2008057871A2 Inhibitors of hepatitis c virus |
| 05/15/2008 | WO2008057862A2 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-ϰB ACTIVITY AND USE THEREOF |
| 05/15/2008 | WO2008056677A1 Reaction reagent for trifluoromethylation |
| 05/15/2008 | WO2008055854A1 Bicyclic heterocycles, medicaments containing said compounds, use thereof, and method for production of same |
| 05/15/2008 | WO2008055669A1 Salt of aliskiren with orotic acid |
| 05/15/2008 | WO2008036843A3 Nitrogen containing substituted heterocycles as platelet adp receptor inhibitors |
| 05/15/2008 | WO2008035359A3 Oximinophenoxyalkanoic acid and phenylalkanoic acid derivatives |
| 05/15/2008 | US20080114158 Yellow anionic disazo dyes |
| 05/15/2008 | US20080114008 Quinazoline Derivatives as Antiviral Agents |
| 05/15/2008 | US20080114002 3-[2-(3-Cyanophenoxy)-4-(trifluoromethyl)phenyl]propanoic acid;prostaglandin D2 inhibitor, orphan receptor CRTH2 antagonist; antiinflammatory, analgesic, antipyretic; respiratory system disorders: asthma and rhinitis; coupling amino/thio-phenyl derivatives with ester followed by hydrolysis to acid |
| 05/15/2008 | US20080113993 Barbituric acid analogs as therapeutic agents |
| 05/15/2008 | US20080113976 asthma, multiple sclerosis, artherosclerosis, and rheumatoid arthritis; Azetidine-1-carboxylic acid {2-[({2-hydroxy-1-[(isopropyl-methyl-amino)-methyl]-pentylcarbamoyl}-methyl)-carbamoyl]-4-trifluoromethyl-phenyl}-amide |
| 05/15/2008 | CA2669187A1 Bicyclic heterocycles, drugs containing said compounds, the use thereof and methods for preparing same |
| 05/15/2008 | CA2665073A1 Salt of aliskiren with orotic acid |
| 05/15/2008 | CA2644333A1 Reaction reagent for trifluoromethylation |
| 05/14/2008 | EP1921070A1 Bicyclic heterocycles, medicaments comprising them, their use and process for their preparation |
| 05/14/2008 | EP1919900A2 Bicyclic heterocycles medicaments comprising said compounds use and method for production thereof |
| 05/14/2008 | EP1919880A2 Rosuvastatin calcium with a low salt by-product content |
| 05/14/2008 | EP1660184A4 17-acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 05/14/2008 | EP1575922B1 Biphenyl derivatives and their use as fungicides |
| 05/14/2008 | EP1485365B1 Sulfonyl-derivatives as novel inhibitors of histone deacetylase |
| 05/14/2008 | EP1446375B1 Dihalogenpropene compounds, method for the production thereof, agents containing said compounds and the use thereof as pest control agents |
| 05/14/2008 | CN101180278A 2-amino-4-phenylquinazoline derivates and their use as HSP90 modulators |
| 05/14/2008 | CN101180277A Method for production of 1-alkyl-3-phenyluracils |
| 05/14/2008 | CN101177427A Compound polycrystalline type alpha and solvate for hypnotism, preparation method and combination including the same |
| 05/14/2008 | CN101177415A Method for preparing new crystal form of anti-cancer compound ZD1839 |
| 05/14/2008 | CN101177414A New crystal form of anti-cancer compound ZD1839, preparation method thereof and medical compound containing the crystal form |
| 05/14/2008 | CN101177413A 6-cyclohexyl methyl substituted S-DABO compound, method for synthesizing same and uses thereof |
| 05/14/2008 | CN101177412A Method for synthesizing acetyl substituted nitrogen heterocycle compounds |
| 05/14/2008 | CN101177385A Aryl sulfonic acid amides and analogues as well as its purpose in curing neural degeneration disease |
| 05/13/2008 | US7371859 Peptide nucleic acid monomers; 1-(4-(benzothiazolyl-, benzoxazolyl-, benzofuranyl-, and benzothiophenyl- sulfonyl)piperidin-3-one-1-ylcarbonylmethyl)adenines; suitable for automatic and parallel synthesis; increased yields |
| 05/13/2008 | US7371858 Guanidinopyrimidinone compounds and phase change inks containing same |
| 05/13/2008 | US7371764 agricultural and horticultural fungal infections of plants; novel N-alkynyl-2-quinolin-(isoquinolin- and quinazolin-)oxyalkylamides; 2-(6-quinolinyloxy)-N-(4-methylpent-2-yn-4-yl) butyramide |
| 05/13/2008 | US7371759 Anticholesterol agents; reducing blood serum lipids; anticancer agents; antiarthritic agents; antiinflammatory agents; antitumor agents; immunosuppressants; obesity; hypotensive agents |
| 05/13/2008 | US7371758 compounds exhibiting antimalarial activity against Plasmodium falciparum lines, including those resistant against pyrimethamine and other antifolates |
| 05/13/2008 | US7371757 Fused heterocycles as inhibitors of glutamate racemase(MURI) |
| 05/13/2008 | US7371753 Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions |
| 05/13/2008 | US7371747 Cyanoalkylamino derivatives as protease inhibitors |
| 05/08/2008 | WO2008053221A2 Process for preparing indol- 5 -oxy- quinazoline derivatives and intermediates |
| 05/08/2008 | WO2008053131A1 Hydroxamates as inhibitors of histone deacetylase |
| 05/08/2008 | WO2008052934A1 Novel substituted pyrimidines as cysteine protease inhibitors |
| 05/08/2008 | WO2008009963A3 Pyrimidine derivatives as modulators of parathyroid hormone receptors |
| 05/08/2008 | US20080108813 Process for the preparation of 7-substituted 3-alkyl-3h-isobenzofuran-1-one derivatives |
| 05/08/2008 | US20080108808 Dipeptidyl peptidase inhibitors |
| 05/08/2008 | US20080108807 Immunosuppressants; autoimmune disease; antiinflammatory agents; multiple sclerosis; rheumatic diseases; antiarthritic agents; aids; for example, 2-{6-[3-Amino-piperidin-1-yl]-3-ethyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-benzonitrile |
| 05/08/2008 | US20080108637 isopropyl ester of N-(2,6-dichlorobenzoyl)-4-(6-iodo-2,4-dioxo-1,2,3,4-tetrahydroquinazoline-3(2H)-yl)-L-phenylalanine; 4 integrin inhibitor; antiinflammatory agent; rheumatoid arthritis, inflammatory bowel diseases, multiple sclerosis, asthma; preservation stability, humidity resistance or solubility; |
| 05/08/2008 | US20080108634 Novel phenylalanine derivatives |
| 05/08/2008 | US20080108614 Substituted 2-Amino-Quinazolin-4-Cn Compounds for Use in the Treatment of Cns Disorders, Pain, Stroke, Addiction and Epilepsy, their Preparation and Use as Intermediates |
| 05/08/2008 | US20080108608 Pyrimidines With Tie2 (Tek) Activity |
| 05/08/2008 | US20080108601 anticancer agents; catalytic hydrogenation |
| 05/08/2008 | US20080104772 Agent for dyeing keratin-based fibers |
| 05/08/2008 | CA2668070A1 Hydroxamates as inhibitors of histone deacetylase |
| 05/08/2008 | CA2667920A1 Process for preparing indol-5-oxy-quinazoline derivatives and intermediates |
| 05/08/2008 | CA2667826A1 Inhibitors of histone deacetylase |
| 05/08/2008 | CA2664430A1 Immunochemically equivalent hiv drug analogs |
| 05/07/2008 | EP1918284A1 Hydrazinopyrimidines as cysteine protease inhibitors |
| 05/07/2008 | EP1918278A1 Sulfonylamino derivatives which inhibit matrix-degrading metalloproteinases |
| 05/07/2008 | EP1917262A1 Piperidine and piperazine derivatives as p2x3 antagonists |
| 05/07/2008 | EP1917246A1 Benzoquinazoline derivatives and their use in treating bone disorders |
| 05/07/2008 | EP1917245A1 Heterocyclic compounds and their use as binding partners for 5-ht5 receptors |
| 05/07/2008 | EP1917244A2 Hetaryl-substituted guanidine compounds and use thereof as binding partners for 5-ht5-receptors |
| 05/07/2008 | EP1917240A1 Immunosuppressant compounds and compositions |
| 05/07/2008 | EP1601670B1 Arylvinylazacycloalkane compounds and methods of preparation and use thereof |
| 05/07/2008 | EP1440064B1 Process for the preparation of (pyrimidin-2-yl)methyl ketones |
| 05/07/2008 | EP1339409B1 Use of rosuvastatin (zd-4522) in the treatment of heterozygous familial hypercholesterolemia |
| 05/07/2008 | CN101175731A Pyrimidine carboxylic acid derivatives and use thereof |
| 05/07/2008 | CN101175730A Method for preparing substituted pyrimidines |
| 05/07/2008 | CN101172983A Substituted phenylacetic acids |
| 05/06/2008 | US7368572 Anticancer agents |
| 05/06/2008 | US7368479 Alpha-sulfonylamino-acetonitriles |
| 05/06/2008 | US7368454 serotonin receptor modulator; antidepressant, anxiolytic agent; drug abuse; schizophrenia |
| 05/06/2008 | US7368453 Quinazolinone compounds with reduced bioaccumulation |
| 05/06/2008 | CA2377803C Phenyl sulfamate derivatives |
| 05/06/2008 | CA2258949C Novel heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases |
| 05/06/2008 | CA2244979C Proton conductor in liquid form |
| 05/02/2008 | WO2008051547A1 Fused bicyclic derivatives of 2,4-diaminopyrimidine as alk and c-met inhibitors |
| 05/02/2008 | WO2008050808A1 2-aminoquinazoline derivative |
| 05/02/2008 | WO2008050168A1 New sulfonamide derivatives as bradykinin antagonists |
| 05/02/2008 | WO2008049645A2 Hydrates of erlotinib hydrochloride |
| 05/02/2008 | CA2669111A1 Fused bicyclic derivatives of 2,4-diaminopyrimidine as alk and c-met inhibitors |
| 05/02/2008 | CA2664347A1 2-phenyl-6-aminocarbonyl-pyrimidine derivatives and their use as p2y12 receptor antagonists |
| 05/01/2008 | US20080103180 CCR9 inhibitors and methods of use thereof |
| 05/01/2008 | US20080103163 Nociceptine antagonists; hydrochloride salts of N-amidino-2-{[2-(4-chlorobenzoylamino)-6-methylquinazolin-4-yl]amino}cyclohexylamine, 1-[1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl]-3-ethyl-1,3-dihydro-2H-benzimidazol-2-one and N-(4-amino-2-methyl-6-quinolyl)-2-[(4-ethylphenoxy)methyl]benzamide |